Skip to main content
Premium Trial:

Request an Annual Quote

Arrowhead to Privately Place $2M in Stock, Warrants

Premium

Arrowhead Research, the parent firm of Calando Pharmaceuticals, announced last week that it has signed agreements to sell at least $2 million in stock and warrants to certain institutional and accredited investors.

Under the terms of the arrangements, the company will sell at least 7.1 million units, which each unit comprising one share of common stock and a warrant to purchase an additional share at $0.50, at $0.30 per unit.

The offering is expected to close this week.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.